A total of 16 hybrid myeloma clones secreting monoclonal antibodies (McAb) 
INTRODUCTION
In man, 60-65 % of serum cholesterol is transported in low-density lipoprotein (LDL; p 1.019-1.063g/ml), a lipoprotein rich in cholesteryl esters and cholesterol which contains a single protein (apoB) as apolipoprotein. ApoB is responsible for the binding of LDL to its receptor, a membrane protein which promotes LDL uptake and degradation in several tissues (Goldstein & Brown, 1977; Brown et al., 1981) .
A lipoprotein homologous with human serum LDL is present in a number of animal species, although in several species high-density lipoprotein (HDL; p 1.063-1.21 g/ml) rather than LDL is the major cholesterol carrier in serum (Chapman, 1980) . In the rabbit, a species which is widely used for studies on lipoproteins and atherosclerosis, 45-50%/ of serum cholesterol is transported in LDL.
In the last few years it has been discovered that the apoB associated with serum VLDL, IDL and LDL is not identical with the apoB associated with chylomicron and chylomicron remnants. Chylomicron and LDL apoB(s) (apoB-48 and apoB-100 respectively) have different Mr values, slightly different amino acid compositions and are synthesized in different tissues [apoB-48 is synthesized in the intestine and apoB-100 is synthesized in the liver (Kane et al., 1980; Kane, 1983) ]. Furthermore, whereas apoB-100 binds with high affinity to the LDL receptor, apoB-48 does not (Hui et al., 1984b) . Nevertheless, the two proteins are immunochemically related, since antisera produced against LDL react with apoB-100 and with apoB-48 (Kane, 1983) . More recently, apolipoproteins homologous with human apoB-100 and apoB-48 have been identified in several animal species, including rabbit (Kroon et al., 1985) .
The availability of antibodies specific for apoB-100 and apoB-48 may be of considerable interest for animal studies on lipoprotein synthesis, turnover and catabolism, as separate receptors control the catabolism of lipoproteins containing apoB-48 or apoB-100 in liver, and the two receptors appear to be under separate genetic Bilheimer et al., 1982) and metabolic (Angelin et al., 1983) control. We report here the derivation and characterization of two sets of rat McAb to rabbit and human LDL. Several McAb react with both apoB-100 and apo-48; others are specific for apoB-100, and do not cross-react with apoB-48.
MATERIALS AND METHODS Isolation of LDL
LDL was isolated and purified from rabbit, human, rhesus monkey (Macaca mulatta), rat and mouse sera by preparative ultracentrifugation in a 50 Ti rotor at 49000 rev./min for 16 h at 4 'C. The density of the serum was Rabbit, rat and mouse LDL contained apoE (3-11 %o) and traces of apoC species (1-3 %O) in addition to apoB-100. LDL protein was measured as described by Markwell et al. (1978) and used to express LDL concentrations. Rabbit and human LDL were labelled with 125I by using a modification of the lactoperoxidase procedure of Marchalonis (1969) .
Immunization with LDL
Groups of four male adult rats (DA and LOU) and mice (C57BLIO and BALB/c) were immunized with rabbit and human LDL in Freund's complete adjuvant (Difco 0638-60-7). Each animal received either 125,ug (rats) or 25 /ag (mice) of LDL as multi-site intramuscular injections. Antibody titre in serum (defined as the highest dilution of serum giving an absorbance reading of twice the background in the enzyme-linked solid-phase assay) was measured before, and 3 weeks after, the primary immunization. As the best antibody response was obtained in rats, rat spleen cells were used to derive the antibody-secreting cell lines. The animal used for the fusion received a second injection of LDL (50 jg intravenously in 0.1 ml of 0.01 M-Tris/HCl/0.15 M-NaCl, pH 7.4) 3 days before isolation of spleen cells for fusion.
Derivation of hybrid myelomas
Derivation of hybrid myelomas was carried out essentially as described by Galfre' & Milstein (1981) (25 ng-2.5,ug/well) and washing the plates with various concentrations of Tween 20 or BSA in TBS. The procedure finally adopted, as described above, was sensitive enough to detect anti-LDL antibodies in hybridoma supernatants diluted 5-10 times with minimal background. The coefficient of variation for the assay was 5.8 % (n = 5). Binding-competition assay Binding-competition assays were performed as described by Fisher & Brown (1980) using a modification of the solid-phase enzyme-linked assay. Plates (96-well) were coated with LDL (25 ng/well). McAb were concentrated 10-fold from the spent culture medium by centrifugation at 10000 g for 10 min at 4°C after incubation for 1 h in ice with (NH4) Assuming the amount ofcompetition between different McAb to be inversely related to the distance between the epitopes which they recognize, a coefficient related to the distance between the different epitopes was calculated and used to derive an epitope map using a clustering technique based on the procedures described by Ward (1963) and Everitt (1981) as implemented in the computer program CLUSTAN (Wishart, 1978) . Antibody blotting of apoB and apoB fragments Antibody blotting of apoB was carried out after SDS/ polyacrylamide-gel electrophoresis of VLDL or LDL protein(s) essentially as described by Burnette (1981) . After electrophoresis, gels were equilibrated for 15 (Fig. 1) . Only three anti-(rabbit LDL) monoclonal IgG species (MAC27, MAC28 and MAC31) showed some reactivity (8-19 %o) with human LDL and none reacted appreciably with rhesus-monkey and rat LDL (Fig. 1) . However, all rat anti-rabbit LDL McAb showed partial cross-reactivity (11-34 %) with mouse LDL (Fig. 1) .
All the anti-(human LDL) McAb except MAC130 reacted equally well with human and rhesus-monkey LDL (Fig. 2) (Fig. 2) . Albeit that only three non-primate species were studied, the data in Fig. 2 (Fig. 3) . One included the epitopes recognized by MAC22, MAC29 and MAC27; the other included the epitopes recognized by MAC23, MAC26 and MAC31. The three McAb grouped in the second cluster appeared to be the one recognizing apoB-48, in addition to apoB-100 and/or apoB-74 (Table 1) .
Binding-competition experiments with anti-(human LDL) McAb The dendrogram shows the data presented in Table 2 analysed by a clustering technique based on the procedure of Ward (1963) as implemented in the computer program CLUSTAN (Wishart, 1978) . This procedure combines those two clusters, P and Q, whose fusion yields the least increase in the error sum of squares. The coefficient shown in the ordinate scale is twice the increase in the error sum of squares caused by the cluster's fusion.
form of detergent-solubilized apoB (Table 1) , did not bind any fragment of apoB-100 ( Fig. 4a and 4b) . The IgG bound various tryptic fragments of apoB-100 (Fig.  4a ) according to four patterns: the first was recognized by MAC22, MAC27 and MAC28, the second was recognized by MAC23 and MAC31, the third was unique for MAC26 and the fourth was unique for MAC29 (Fig. 4a) . That the epitope recognized by MAC22 and MAC27 is related to, but not identical with, that recognized by MAC28 was shown by the antibody blots of the peptides generated by digestion of apoB-100 with staphylococcal V8 proteinase (Fig. 4b) . Whereas the V8-proteinase peptide maps for MAC22 and MAC27 appeared only slightly different, that of MAC28 was clearly different (Fig. 4b) . The tryptic peptide maps for these McAb were identical (Fig. 4a) . Only minor differences were detected in the V8-proteinase peptide maps for MAC23 and MAC31 (Fig. 4b) , confirming the proximity of the epitopes recognized by these McAb as indicated by their specificity for the different forms of apoB (Table 1 ) and the results of the binding competition experiments (Table 2 and Fig. 3 ). The four rat McAb to human LDL able to bind detergent-solubilized apoB (MAC 127, MAC 129, MAC131 and MAC132) were also studied for their ability to bind to specific apoB fragments generated by partial proteolysis (Fig. 5) . Each McAb recognized a specific set of peptides generated either by trypsin (Fig.  5a ) or staphylococcal V8 proteinase (Fig. 5b) , thus confirming the unique epitope specificity of these McAb.
Inhibition of binding of 125I-LDL to the LDL receptor by anti-LDL McAb
Since it is known that apoB-100, but not apoB-48, is capable of binding to the LDL receptor, three anti-(rabbit LDL) McAb (MAC27, MAC28 and MAC29), which reacted only with apoB-100 (Table 1) were selected for studies on their ability to interfere with the binding of '25l-LDL to its receptor. These McAb were purified from ascitic fluid and incubated at several concentrations with a fixed concentration of 125I-LDL. These mixtures were then incubated with rabbit fibroblasts at 4°C and the amount of '25I-LDL bound to the fibroblast LDL receptor in the presence or absence of McAb was determined (Fig. 6) . MAC28 was able to reduce the binding of 125I-LDL to the fibroblast receptor (50 0% inhibition at a 10-fold molar excess of McAb). Concentrations 10-20 times higher of MAC27 and MAC29 were required in order to produce the same inhibition of binding (Fig. 6) .
The two McAb to human LDL which only reacted with apoB-100 and apoB-74 (MAC127) or with apoB- ".
Om.
-29 Fig. 4 . Reactivity of rat McAb to rabbit LDL with fragments of ApoB-100 generated by trypsin or staphylococcal V8 proteinase Rabbit LDL (p 1.019-1.063 g/ml) was incubated for 2 h at room temperature with trypsin (Sigma T8253) (a) or staphylococcal V8 proteinase (Miles, 39-900) (b) in 0.05 MNa2HPO4/NaH2PO4, pH 7.8, at an enzyme/substrate ratio of 1: 100 (w/w) (Drapeau, 1977) . The reaction was stopped by addition of SDS and 2-mercaptoethanol, followed by electrophoresis. ApoB-100 fragments were separated on a polyacrylamide (125-200 g/l) gel (Laemmli, 1970 Mao et al., 1982 Mao et al., , 1983 Marcel et al., 1982; Patton et al., 1982; Tikkanen et al., 1982; Tsao et al., 1982; Milne et al., 1983; Watt & Watt, 1983; Hui et al., 1984a) and rat LDL (Sparks et al., 1986) .
We have reported here the derivation of two sets of rat McAb to rabbit and human LDL and their characterization in terms of species specificity, apoB specificity and epitope specificity.
Whereas it is generally assumed that LDL apoB (apoB-100) from different species shows considerable immunological cross-reactivity (Goldstein & Chapman, 1976; Chapman 1980) , the data presented here indicate that such cross-reactivity is related to (i) the species being considered, (ii) the antibody class and (iii) the epitope specificity of the antibody (Figs. 1 and 2 ). This indicates that certain epitopes of apoB-100 are more conserved than others among the different species. Recent data from other laboratories indicate that the LDL-receptor apoB-100 recognition site is very conserved in different species (Nelson et al., 1984; Young et al., 1986) . Since it is known, however, that the interaction of LDL with the LDL receptor is considerably species-specific (Innerarity et al., 1980; Drevon et al., 1981) , it could be of interest to know if the cross-reactivity of animal LDL with antibodies directed to the receptor site of human LDL correlates with the ability of animal lipoproteins to interact with the human LDL receptor.
The availability of McAb specific for apoB-100, and possibly apoB-48, is of potential interest for the quantification of these apolipoproteins in serum, as triacylglycerol-rich lipoproteins containing either apoB-48 or apoB-100 cannot be completely separated by physical methods (Lindgren & Jensen, 1972) . IDL and LDL containing apoB-100 are cleared from the blood largely through the hepatic LDL receptor (reviewed by Goldstein et al., 1983) . Chylomicron remnants contain apoE in addition to apoB-48, and thus could bind both to the remnant (apoE) receptor and the LDL receptor. However, studies in the WHHL rabbit, which has a genetic deficiency of LDL receptor, have shown that hepatic LDL receptor is essential for the clearance of IDL and LDL from serum, but not for the clearance of chylomicron remnants (Tsao et al., 1982) , VLDL subfractions and LDL subfractions (Tsao et al., 1982; Mao et al., 1982) . Two approaches, however, may overcome this limitation. The first is based on the use of mixtures of two or more McAb (Mao et al., 1983; Marcovina et al., 1985) ; the second involves the use of a detergent-based immunoassay. Work on these lines is in progress in a number of laboratories. Furthermore, McAb to human LDL have recently been used for the identification of genetic polymorphism associated with LDL (Schumaker et al., 1984) and the isolation of cDNA species complementary to apoB mRNA (Huang et (Fig. 6 ). Concentrations 10 times higher of MAC27 and MAC29 were required to produce the same degree of inhibition (Fig. 5) . None of the McAb to human LDL which we have produced was able to interfere with the binding of human 125I-LDL to the receptor. McAb able to inhibit the binding of human 125I-LDL to the LDL receptor have been prepared by Tikkanen et al. (1982 ), Milne et al. (1983 and Hui et al. (1984a) . These antibodies may prove useful in identifying the LDLreceptor binding site on apoB and define the minimal sequence of apoB required for binding to the receptor. Furthermore anti-LDL antibodies specific for the receptor binding site may permit the production of antiidiotypic anti-receptor antibodies. Anti-idiotypic antibodies to the insulin receptor (Shechter et al., 1982) , to the acetylcholine receptor (Cleveland et al., 1983) and to a receptor for the T-cell I-J determinant (Zupko et al., 1985) have been prepared, and it is conceivable that anti-(LDL receptor) antibodies could be derived using this approach. 
